ALLYSA RUESCHENBERG: Open Payments
NPI 1689115446 · ARROYO GRANDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $273 · 2025 $675
Food & beverage: $590Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $123 |
| Madrigal Pharmaceuticals | 1 | $123 |
| ABBVIE INC. | 2 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $104 |
| Aimmune Therapeutics, Inc. | 1 | $99 |
| Janssen Biotech, Inc. | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: Wegovy, REZDIFFRA, XIFAXAN, ZENPEP, SKYRIZI, TREMFYA, RINVOQ.
Industry payments across CA — which companies pay providers there.
